Protein Name |
Origin of gene |
Pack Size |
Cat.# |
Price |
gB
11-67 aa |
C M V |
0.2 mg |
Q3285 |
£250 |
Pp28 (UL99) 130-160
aa |
C M V |
0.2 mg |
Q3281 |
£250 |
Pp150 (UL32)
1011-1048 aa |
C M V |
0.2 mg |
Q3283 |
£250 |
Pp65 (UL83) 297-510
aa |
C M V |
0.2 mg |
Q3287 |
£250 |
Pp52(UL44) 202-434
aa |
C M V |
0.2 mg |
Q3289 |
£250 |
Pp38 (UL80a) 117-373
aa |
C M V |
0.2 mg |
Q3291 |
£250 |
gE
protein 19-153 aa |
Tick-born
Encephalitis Virus |
0.2 mg |
Q3351 |
£250 |
HAV VP1-P2A
722-830aa |
Hepatitis A Virus |
0.2 mg |
Q3121 |
£250 |
HAV VP4-VP2
55-164aa |
Hepatitis A Virus |
0.2 mg |
Q3123 |
£250 |
HAV P2C-P3A
1492-1606aa |
Hepatitis A Virus |
0.2 mg |
Q3125 |
£250 |
HAV P3C 1643-1743aa |
Hepatitis A Virus |
0.2 mg |
Q3127 |
£250 |
HAV VP3 304-415aa |
Hepatitis A Virus |
0.2 mg |
Q3129 |
£250 |
HAV VP1-P2A
669-782aa |
Hepatitis A Virus |
0.2 mg |
Q3131 |
£250 |
HAV
HAV P2C 1121-1234aa |
Hepatitis A Virus |
0.2 mg |
Q3133 |
£250 |
HAV P2C-P3A
1392-1521aa |
Hepatitis A Virus |
0.2 mg |
Q3135 |
£250 |
HBV core protein |
Hepatitis B Virus |
0.2 mg |
Q3141 |
£250 |
HBeAg
protein |
Hepatitis B Virus |
0.2 mg |
Q3143 |
£250 |
HCV core 2-119aa (genotype
1a) |
Hepatitis C Virus |
0.2 mg |
Q3151 |
£120 |
HCV core 2-119aa (genotype
1b) |
Hepatitis C Virus |
0.2 mg |
Q3153 |
£120 |
HCV core 2-119aa (genotype
2a) |
Hepatitis C Virus |
0.2 mg |
Q3155 |
£120 |
HCV core 2-119aa (genotype
2b) |
Hepatitis C Virus |
0.2 mg |
Q3157 |
£120 |
HCV core 2-119aa (genotype
3a) |
Hepatitis C Virus |
0.2 mg |
Q3159 |
£120 |
HCV core 2-119aa (genotype
3b) |
Hepatitis C Virus |
0.2 mg |
Q3161 |
£120 |
HCV core 2-119aa (genotype
3/10) |
Hepatitis C Virus |
0.2 mg |
Q3163 |
£120 |
HCV core 2-119aa (genotype
4) |
Hepatitis C Virus |
0.2 mg |
Q3165 |
£120 |
HCV core 2-119aa (genotype
5) |
Hepatitis C Virus |
0.2 mg |
Q3167 |
£120 |
HCV core 2-119aa (genotype
6a) |
Hepatitis C Virus |
0.2 mg |
Q3169 |
£120 |
HCV core 24 |
Hepatitis C Virus |
0.2 mg |
Q3171 |
£120 |
HCV core 105-302 aa |
Hepatitis C Virus |
0.2 mg |
Q3173 |
£120 |
HCV NS3 1192-1456aa
(genotype
1a) |
Hepatitis C Virus |
0.2 mg |
Q3175 |
£120 |
HCV NS3 1192-1456aa
(genotype
1b) |
Hepatitis C Virus |
0.2 mg |
Q3177 |
£120 |
HCV NS3 1192-1456aa
(genotype
2b) |
Hepatitis C Virus |
0.2 mg |
Q3179 |
£120 |
HCV NS3 1192-1456aa
(genotype
2c) |
Hepatitis C Virus |
0.2 mg |
Q3181 |
£120 |
HCV NS3 1192-1456aa
(genotype 5) |
Hepatitis C Virus |
0.2 mg |
Q3183 |
£120 |
HCV NS3 1192-1456aa
(genotype
6a) |
Hepatitis C Virus |
0.2 mg |
Q3185 |
£120 |
HCV NS3 1359-1456aa
(genotype
1a) |
Hepatitis C Virus |
0.2 mg |
Q3187 |
£120 |
HCV NS3 1359-1456aa
(genotype
1b) |
Hepatitis C Virus |
0.2 mg |
Q3189 |
£120 |
HCV NS3 1359-1456aa
(genotype
2b) |
Hepatitis C Virus |
0.2 mg |
Q3191 |
£120 |
HCV NS3 1359-1456aa
(genotype
2c) |
Hepatitis C Virus |
0.2 mg |
Q3193 |
£120 |
HCV NS3 1359-1456aa
(genotype 3) |
Hepatitis C Virus |
0.2 mg |
Q3195 |
£120 |
HCV NS3 1359-1456aa
(genotype 4) |
Hepatitis C Virus |
0.2 mg |
Q3197 |
£120 |
HCV NS3 1359-1456aa
(genotype 5) |
Hepatitis C Virus |
0.2 mg |
Q3199 |
£120 |
HCV NS3 1359-1456aa
(genotype 6) |
Hepatitis C Virus |
0.2 mg |
Q3201 |
£120 |
HCV NS4 artificial
mosaic protein (1691-1710aa,
1712-1733aa, 1921-1940aa, from 1,2,3.5 genotypes) |
Hepatitis C Virus |
0.2 mg |
Q3203 |
£200 |
HCV NS4 1916-1947aa |
Hepatitis C Virus |
0.2 mg |
Q3205 |
£120 |
HCV NS5 2061-2302aa |
Hepatitis C Virus |
0.2 mg |
Q3207 |
£120 |
HCV NS5 2212-2313aa
(genotype
1a) |
Hepatitis C Virus |
0.2 mg |
Q3209 |
£120 |
HCV NS5 2212-2313aa
(genotype
1b) |
Hepatitis C Virus |
0.2 mg |
Q3211 |
£120 |
HCV NS5 2212-2313aa
(genotype
2a) |
Hepatitis C Virus |
0.2 mg |
Q3213 |
£120 |
HCV NS5 2212-2313aa
(genotype
2b) |
Hepatitis C Virus |
0.2 mg |
Q3215 |
£120 |
HCV NS5 2212-2313aa
(genotype
3a) |
Hepatitis C Virus |
0.2 mg |
Q3217 |
£120 |
HCV NS5 2212-2313aa
(genotype
3b) |
Hepatitis C Virus |
0.2 mg |
Q3219 |
£120 |
HCV NS5 2212-2313aa
(genotype 4) |
Hepatitis C Virus |
0.2 mg |
Q3221 |
£120 |
HCV NS5 2212-2313aa
(genotype 5) |
Hepatitis C Virus |
0.2 mg |
Q3223 |
£120 |
HCV NS5 2212-2313aa
(genotype
6a) |
Hepatitis C Virus |
0.2 mg |
Q3225 |
£120 |
HDV Ag
|
Hepatitis D Virus |
0.2 mg |
Q3227 |
£250 |
HEV mosaic protein
contains 12 HEV immunodominant regions from
ORF2 and ORF3 |
Hepatitis E Virus |
0.2 mg |
Q3231 |
£250 |
HEV ORF2 452-617aa |
Hepatitis E Virus |
0.2 mg |
Q3233 |
£250 |
HEV mosaic
protein contains 4 HEV immunodominant
regions from ORF2 and ORF3 |
Hepatitis E Virus |
0.2 mg |
Q3235 |
£250 |
HHV-4 p18 1-119aa |
Epstain-Barr
Virus |
0.2 mg |
Q3341 |
£250 |
HHV-4 p23 1-162aa |
Epstain-Barr
Virus |
0.2 mg |
Q3343 |
£250 |
HHV-4 mosaic protein
EBNA1 (1-90/408-498aa) |
Epstain-Barr
Virus |
0.2 mg |
Q3345 |
£350 |
HHV-4 EA 306-390aa |
Epstain-Barr
Virus |
0.2 mg |
Q3347 |
£250 |
HIV-1
p17/24/gp120-gp41 |
H I V |
0.2 mg |
Q3241 |
£120 |
HIV-1 p17/24/gp120 |
H I V |
0.2 mg |
Q3243 |
£120 |
HIV-1 gp41 |
H I V |
0.2 mg |
Q3245 |
£120 |
HIV-1 p17-p24 |
H I V |
0.2 mg |
Q3247 |
£120 |
HIV-2 gp32 |
H I V |
0.2 mg |
Q3249 |
£120 |
HIV-1 p24 |
H I V |
0.2 mg |
Q3251 |
£120 |
HIV 1,2 envelope,
conjugated.
Specifity
- HIV-1,2 envelope antibodies |
H I V |
0.2 mg |
Q3253 |
£350 |
HIV 1 envelope.
Specifity
- HIV-1 and HIV-O antibodies |
H I V |
0.2 mg |
Q3255 |
£250 |
HIV 1 p24 core.
Specifity
- HIV-1 antibodies |
H I V |
0.2 mg |
Q3257 |
£250 |
HIV type O envelope.
Synthetic HIV
type-O peptide. Specifity - HIV-Type O
antibodies |
H I V |
0.2 mg |
Q3259 |
£250 |
HIV 2 gp32
envelope.Specifity
- HIV-2 antibodies |
H I V |
0.2 mg |
Q3261 |
£250 |
HIV 2 gp36 envelope.
Synthetic
HIV-2 Peptide. Specifity - HIV-2 antibodies. |
H I V |
0.2 mg |
Q3263 |
£250 |
HLTV-I envelope.
Specifity
- HTLV-I/II envelope antibodies |
Human Lymphotropic
Virus |
0.2 mg |
Q3311 |
£250 |
HLTV-I p24 core.
Specifity
- HTLV-I core antibodies |
Human Lymphotropic
Virus |
0.2 mg |
Q3313 |
£250 |
HLTV-I virus mosaic
protein contains the gp21/gp46 374-400/190-207aa) |
Human Lymphotropic
Virus |
0.2 mg |
Q3315 |
£350 |
HSV-1
gD 266-394aa |
H S V |
0.2 mg |
Q3271 |
£250 |
HSV-2
gD 266-394aa |
H S V |
0.2 mg |
Q3273 |
£250 |
HSV-2
qG 525-578aa |
H S V |
0.2 mg |
Q3275 |
£250 |
HSV-1
gG 84-175aa |
H S V |
0.2 mg |
Q3277 |
£250 |
Mosaic protein
TmpA (P41: 23-41aa, 288-325) |
Treponema
pallidum |
0.2 mg |
Q3104 |
£350 |
P17
|
Treponema
pallidum |
0.2 mg |
Q3101 |
£250 |
P41
|
Treponema
pallidum |
0.2 mg |
Q3102 |
£250 |
P47
|
Treponema
pallidum |
0.2 mg |
Q3103 |
£250 |
P24 (GRA1) 57-149
aa |
Toxoplasma
gondii |
0.2 mg |
Q3113 |
£250 |
P29 (GRA7) 24-100
aa |
Toxoplasma
gondii |
0.2 mg |
Q3115 |
£250 |
P30 (SAG1) 45-198
aa |
Toxoplasma
gondii |
0.2 mg |
Q3117 |
£250 |
MIC 3
protein 234-306 aa |
Toxoplasma
gondii |
0.2 mg |
Q3111 |
£250 |
Rubellavirus
E1 regions 157-176/374-390/213-239aa |
Rubella Virus |
0.2 mg |
Q3361 |
£350 |
Rubellavirus
E2 regions 31-105aa |
Rubella Virus |
0.2 mg |
Q3363 |
£250 |
Rubellavirus
C regions 1-123aa |
Rubella Virus |
0.2 mg |
Q3365 |
£250 |
SARS-Associated
Coronavirus E recombinant protein |
SARS |
0.2 mg |
Q3321 |
£350 |
SARS-Associated
Coronavirus
Nucleocapsid recombinant protein N |
SARS |
0.2 mg |
Q3323 |
£350 |
SARS-Associated
Coronavirus
Nucleocapsid recombinant protein C |
SARS |
0.2 mg |
Q3325 |
£350 |
SARS-Associated
Coronavirus M recombinant protein |
SARS |
0.2 mg |
Q3327 |
£350 |
SARS-Associated
Coronavirus Spike mosaic recombinant protein
S(N) |
SARS |
0.2 mg |
Q3329 |
£350 |
SARS-Associated
Coronavirus Spike mosaic recombinant protein
S(M) 408-470/540-573aa |
SARS |
0.2 mg |
Q3331 |
£350 |
SARS-Associated
Coronavirus Spike mosaic recombinant protein
S(C) |
SARS |
0.2 mg |
Q3333 |
£350 |
VZV
gE 48-135aa |
Varicella
Zoster Virus |
0.2 mg |
Q3301 |
£250 |
VZV ORF9
(6-28aa)+(76-100aa) |
Varicella
Zoster Virus |
0.2 mg |
Q3303 |
£250 |
VZV ORF26
(9-33aa)+(184-208aa) |
Varicella
Zoster Virus |
0.2 mg |
Q3305 |
£250 |
|
|
|
|
|
Cytokines |
|
|
|
|
Erythropoietin,
EPO |
human |
0.1 mg |
Q4001 |
£150 |
Interferon- α 2b, IFN-α
2 (IFN- α2b) |
human |
0.1 mg |
Q4003 |
£150 |
Interferon- γ, IFN- γ |
human |
0.1 mg |
Q4005 |
£150 |
Interleukin-1 α, IL-1α |
human |
0.1 mg |
Q4007 |
£250 |
Interleukin-1 Receptor
antagonist, IL-1Ra |
human |
0.1 mg |
Q4011 |
£250 |